All industries, including biotechnology, are faced with a drastically different economic environment from that of four or five years ago. To get a sense of how a key biotech supplier that operates on ...
Recursion is hosting about 60 investors and analysts at its headquarters in Utah. It has generated tons of data with AI and robots, aiming to find a better way to make drugs. Recursion, which has four ...
In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal finalized in July of the same year. InstaDeep, whose exit is currently the ...
Dr. Frank Bedu-Addo has served as President, CEO and a director of PDS Biotechnology Corporation since its inception in 2005. Dr. Bedu-Addo is a veteran biotech executive with experience successfully ...
NEW YORK, NY / ACCESSWIRE / December 5, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently ...
Alan H. Auerbach has served as Chairman of the Board and as CEO and President of Puma Biotechnology, Inc. since its inception. Before joining Puma, Mr. Auerbach served as Founder, CEO, President and a ...
Germany’s Merck KGaA is betting on artificial-intelligence partnerships to develop new drugs, but refraining from bringing in external expertise through acquisitions, the head of the group’s ...
As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results